IBM Plunges 22.6% on Grim Q2 Preliminary Results, Undermining AI Conversion Thesis

What happened

IBM (NYSE:IBM) shares collapsed 22.6% to $224.88 after the company issued weaker-than-expected preliminary second-quarter results, a sharp reversal from the enterprise AI narrative that had been supporting the stock. The update suggests that key assumptions in the AI conversion thesis, namely that Consulting revenue would accelerate and margins would improve, are failing to materialize. This comes after a first quarter where Consulting constant-currency growth was only 0.9% and segment margin was 10.6%, already below the thresholds needed to justify the previous valuation. The DeepValue report had pegged the bear-case value at $255, a level the stock has now breached, indicating that even pessimistic scenarios assumed better execution. Without immediate evidence of a recovery in Consulting and Software growth, the stock is now priced for a fundamental deterioration that may take multiple quarters to reverse.

Implication

The immediate risk is that the stock may continue to slide as the market reprices IBM for slower software growth and persistent weakness in its AI consulting pipeline. Investors should avoid adding positions until there is clear evidence of a turnaround in Consulting constant-currency growth above 2% and margin recovery above 11%, which appears unlikely in the near term. The DeepValue report's attractive entry of $270 is now above the current price, but the lack of a catalyst suggests waiting for the full Q2 release and management guidance. Free cash flow and backlog provide some floor, but debt levels and acquisition dilution amplify downside if revenue disappoints. A re-assessment window of 6-12 months is warranted, during which investors should focus on the next quarter's signings and margin trajectory.

Thesis delta

The core thesis that AI backlog would convert into higher-margin Consulting revenue and software growth has been dealt a severe blow by the preliminary Q2 miss, which indicates that conversion is not happening as hoped. The stock's plunge below the previous bear-case $255 suggests the market now anticipates a worse outcome than the most pessimistic scenario modeled. The rating should shift from WAIT to a more defensive stance until there is tangible proof of execution improvement.